Status:

COMPLETED

Pharmacokinetics of Neostigmine and Glycopyrrolate

Lead Sponsor:

James J. Peters Veterans Affairs Medical Center

Conditions:

Spinal Cord Injuries

Constipation

Eligibility:

All Genders

18-70 years

Phase:

EARLY_PHASE1

Brief Summary

A group of 6 able-bodied healthy volunteers will receive Neostigmine (NEO) and Glycopyrrolate (GLY) intravenously and via 2 methods of Iontophoresis (ION): one-patch and two-patch administration, with...

Detailed Description

The maximum dose of NEO is limited to 10.0 mg and the dose of GLY to 2.0 mg per subject per administration. Subjects will be asked to arrive at the Spinal Cord Research Center at the JJP VAMC (Room 7A...

Eligibility Criteria

Inclusion

  • Male or Female
  • Age 18-70 years

Exclusion

  • Previous adverse reaction or hypersensitivity to electrical stimulation,
  • Known sensitivity to neostigmine or glycopyrrolate,
  • History of mechanical obstruction of the GI or urinary tract,
  • Myocardial infarction within 6 months of trial,
  • Malignant and/or Uncontrollable Hypertension Defined by a blood pressure reading of 160/100 mmHg or higher with or without taking 3 or more different classes of anti-hypertensive medications,
  • Organ damage (heart \& kidney) and/or TIA-CVA as a result of hypertension,
  • Known past history of coronary artery disease or bradyarrhythmia,
  • Symptomatic orthostatic hypotension
  • Deep brain stimulation
  • Pregnancy (women who are sexually active and of childbearing potential must utilize a method of contraception and agree to maintain a contraceptive method until completion of the study),
  • Lactating, nursing females
  • Inability to provide informed consent signaled by MoCA cognitive test score of 20 or less,
  • History of ingrown hair folliculitis,
  • Concurrent illness and fever,
  • Concurrent participation in a research study,
  • VA employee.

Key Trial Info

Start Date :

March 9 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 20 2022

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT04027972

Start Date

March 9 2020

End Date

December 20 2022

Last Update

September 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

James J Peters VA Medical Center

The Bronx, New York, United States, 10468